Literature DB >> 10527943

Identification of protein kinase C phosphorylation sites in the angiotensin II (AT1A) receptor.

H Qian1, L Pipolo, W G Thomas.   

Abstract

Protein kinase C (PKC) phosphorylates the C-terminus of the type 1 angiotensin II receptor (AT(1)), although the exact site(s) of phosphorylation are unidentified. In the present study, we examined the phosphorylation of epitope-tagged wild-type AT(1A) receptors, transiently expressed in Chinese hamster ovary K1 cells, in response to angiotensin II (AngII) and following selective activation and inhibition of PKC. This phosphorylation was compared with mutant receptors where C-terminal serine residues (Ser(331), Ser(338) and Ser(348)) within three putative PKC consensus sites were replaced with alanine, either individually or in combination. Stimulation by AngII or the phorbol ester PMA to activate PKC induced an increase in phosphorylation of the wild-type AT(1A) receptor, which was prevented by truncation of the receptor C-terminus to remove the last 34 amino acids, including Ser(331), Ser(338) and Ser(348). Whereas single alanine mutation (Ser(331)Ala, Ser(338)Ala and Ser(348)Ala) resulted in decreased receptor phosphorylation, no single mutant completely inhibited either AngII- or PMA-induced phosphorylation. Combined mutation of the three PKC consensus sites caused an approximately 70% reduction in PMA-mediated phosphorylation. The approximately 60% reduction in AngII (1 microM)-induced phosphorylation of this triple mutant and the partial inhibition of wild-type receptor phosphorylation by bisindolylmaleimide, a specific PKC inhibitor, suggest a significant contribution of PKC to agonist-stimulated regulation. The ratio of PKC to total receptor phosphorylation was greatest at low doses of AngII (1 nM), consistent with the idea that PKC phosphorylates and regulates receptor function at low levels of stimulation, whereas phosphorylation by other kinases is more prevalent at high levels of agonist stimulation. To determine if a single PKC site is favoured when the contribution of PKC varies, the phosphorylation of wild-type and mutant receptors was examined over a range of AngII concentrations (0, 1, 10 and 100 nM). At all AngII concentrations, single mutation of Ser(331), Ser(338) or Ser(348) was incapable of completely preventing receptor phosphorylation, suggesting no clear preference for PKC consensus-site utilization. Together, these results indicate a redundancy in PKC phosphorylation of the AT(1A) receptor, whereby all three consensus sites are utilized to some degree following homologous (AngII) and heterologous (PMA) stimulation. The contribution of PKC phosphorylation to receptor regulation is unclear, but multiple PKC phosphorylation of the AT(1A) receptor may allow independent and/or complementary events to occur at the three separate sites of the C-terminus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527943      PMCID: PMC1220596     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  How to estimate the total receptor concentration when the specific radioactivity of the ligand is unknown.

Authors:  S Swillens
Journal:  Trends Pharmacol Sci       Date:  1992-12       Impact factor: 14.819

Review 2.  Molecular biology and signaling of angiotensin receptors: an overview.

Authors:  T Inagami
Journal:  J Am Soc Nephrol       Date:  1999-01       Impact factor: 10.121

3.  Angiotensin II signaling in vascular smooth muscle. New concepts.

Authors:  K K Griendling; M Ushio-Fukai; B Lassègue; R W Alexander
Journal:  Hypertension       Date:  1997-01       Impact factor: 10.190

Review 4.  Regulatory mechanisms that modulate signalling by G-protein-coupled receptors.

Authors:  S K Böhm; E F Grady; N W Bunnett
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

5.  A domain for G protein coupling in carboxyl-terminal tail of rat angiotensin II receptor type 1A.

Authors:  T Sano; K Ohyama; Y Yamano; Y Nakagomi; S Nakazawa; M Kikyo; H Shirai; J S Blank; J H Exton; T Inagami
Journal:  J Biol Chem       Date:  1997-09-19       Impact factor: 5.157

6.  Potentiation of angiotensin II-stimulated phosphoinositide hydrolysis, calcium mobilization and contraction of renal mesangial cells upon down-regulation of protein kinase C.

Authors:  J Pfeilschifter; J Fandrey; M Ochsner; S Whitebread; M de Gasparo
Journal:  FEBS Lett       Date:  1990-02-26       Impact factor: 4.124

7.  Dependence of agonist activation on a conserved apolar residue in the third intracellular loop of the AT1 angiotensin receptor.

Authors:  L Hunyady; M Zhang; G Jagadeesh; M Bor; T Balla; K J Catt
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

8.  Desensitization of endogenous angiotensin II receptors in Xenopus oocytes: a role of protein kinase C.

Authors:  H Sakuta; M Sekiguchi; K Okamoto; Y Sakai
Journal:  Eur J Pharmacol       Date:  1991-09-12       Impact factor: 4.432

9.  Angiotensin-induced desensitization of the phosphoinositide pathway in cardiac cells occurs at the level of the receptor.

Authors:  M M Abdellatif; C F Neubauer; W J Lederer; T B Rogers
Journal:  Circ Res       Date:  1991-09       Impact factor: 17.367

10.  Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.

Authors:  L M Luttrell; S S Ferguson; Y Daaka; W E Miller; S Maudsley; G J Della Rocca; F Lin; H Kawakatsu; K Owada; D K Luttrell; M G Caron; R J Lefkowitz
Journal:  Science       Date:  1999-01-29       Impact factor: 47.728

View more
  7 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

2.  Heterologous phosphorylation-induced formation of a stability lock permits regulation of inactive receptors by β-arrestins.

Authors:  András D Tóth; Susanne Prokop; Pál Gyombolai; Péter Várnai; András Balla; Vsevolod V Gurevich; László Hunyady; Gábor Turu
Journal:  J Biol Chem       Date:  2017-11-16       Impact factor: 5.157

3.  Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling.

Authors:  Jihee Kim; Seungkirl Ahn; Xiu-Rong Ren; Erin J Whalen; Eric Reiter; Huijun Wei; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-25       Impact factor: 11.205

4.  Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors 1 and 2.

Authors:  Daniel Clayton; Iresha Hanchapola; Walter G Thomas; Robert E Widdop; Alexander I Smith; Patrick Perlmutter; Marie-Isabel Aguilar
Journal:  Front Pharmacol       Date:  2015-01-30       Impact factor: 5.810

5.  Protein kinase C δ signaling is required for dietary prebiotic-induced strengthening of intestinal epithelial barrier function.

Authors:  Richard Y Wu; Majd Abdullah; Pekka Määttänen; Ana Victoria C Pilar; Erin Scruten; Kathene C Johnson-Henry; Scott Napper; Catherine O'Brien; Nicola L Jones; Philip M Sherman
Journal:  Sci Rep       Date:  2017-01-18       Impact factor: 4.379

Review 6.  The Role of β-Arrestin Proteins in Organization of Signaling and Regulation of the AT1 Angiotensin Receptor.

Authors:  Gábor Turu; András Balla; László Hunyady
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-06       Impact factor: 5.555

Review 7.  Type 1 angiotensin receptor pharmacology: signaling beyond G proteins.

Authors:  Cristina Oro; Hongwei Qian; Walter G Thomas
Journal:  Pharmacol Ther       Date:  2006-10-14       Impact factor: 12.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.